Oncologic Agents in Sterically Stabilized Liposomes: Basic Considerations
- 1 January 1998
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetics of long-circulating liposomesAdvanced Drug Delivery Reviews, 1995
- Pharmacokinetics and anti‐tumor activity of vincristine encapsulated in sterically stabilized liposomesInternational Journal of Cancer, 1995
- Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.Journal of Clinical Oncology, 1995
- Stabilization of Topotecan in Low pH Liposomes Composed of DistearoylphosphatidylcholineJournal of Pharmaceutical Sciences, 1994
- Clinical Studies of Liposome-Encapsulated DoxorubicinActa Oncologica, 1994
- Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation timesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- Gelation of liposome interior A novel method for drug encapsulationFEBS Letters, 1992
- Pharmacokinetics of stealth versus conventional liposomes: effect of doseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Studies on the myelosuppressive activity of doxorubicin entrapped in liposomesCancer Chemotherapy and Pharmacology, 1990
- Uptake of adriamycin into large unilamellar vesicles in response to a pH gradientBiochimica et Biophysica Acta (BBA) - Biomembranes, 1986